Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination.

Published in: Journal of ophthalmic inflammation and infection (2021)

VKH disease results from an autoimmune process directed against melanocyte associated antigens which can be controlled when early and sustained immunosuppressive treatment is introduced. It seems that anti-SARS-CoV-2 vaccination can be at the origin of reactivation of long-time controlled disease.

Keyphrases

sars cov
respiratory syndrome coronavirus
multiple sclerosis
dendritic cells
coronavirus disease
combination therapy